ADNI-3: F18-AV-1451 as an imaging biomarker for Alzheimer's disease

被引：0
|
作者：
Cardenas, Janet [1 ]
Tucker, Katie [2 ]
Riehle, Lisa [1 ]
Dillehay, Gary [1 ]
机构：
[1] Northwestern Mem Hosp, Chicago, IL 60611 USA
[2] Northwestern Mem Hosp, Naperville, IL USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2018年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
2149
引用
收藏
页数：1
相关论文
共 50 条
  • [21] PATHOLOGICAL TAU SIGNAL IN HUNTINGTON'S DISEASE - AN IN VIVO [18F]-AV-1451 PET IMAGING REPORT
    Reetz, Kathrin
    Giehl, Kathrin
    Dogan, Imis
    Werner, Cornelius J.
    Hammes, Jochen
    Schulz, Joerg B.
    Neumaier, Bernd
    Drzezga, Alexander
    van Eimeren, Thilo
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A44 - A44
  • [22] Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer’s disease and supporting differential diagnosis
    Wenyan Zhang
    Shuoyan Xu
    Hongmei Yu
    Xuena Li
    Zhuangzhuang Jin
    Yaming Li
    Zhiyi He
    [J]. Annals of Nuclear Medicine, 2021, 35 : 139 - 147
  • [23] Radioactive synthesis of tau PET imaging agent 18F-AV-1451 and its role in monitoring the progression of Alzheimer's disease and supporting differential diagnosis
    Zhang, Wenyan
    Xu, Shuoyan
    Yu, Hongmei
    Li, Xuena
    Jin, Zhuangzhuang
    Li, Yaming
    He, Zhiyi
    [J]. ANNALS OF NUCLEAR MEDICINE, 2021, 35 (02) : 139 - 147
  • [24] Quantitative 18F-AV1451 Brain Tau PET Imaging in Cognitively Normal Older Adults, Mild Cognitive Impairment, and Alzheimer's Disease Patients
    Zhao, Qian
    Liu, Min
    Ha, Lingxia
    Zhou, Yun
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [25] 18F-AV-1451 in Parkinson's Disease with and without dementia and in Dementia with Lewy Bodies
    Smith, Ruben
    Scholl, Michael
    Londos, Elisabet
    Ohlsson, Tomas
    Hansson, Oskar
    [J]. SCIENTIFIC REPORTS, 2018, 8
  • [26] Principal component analysis of [18F]-AV-1451 tau PET in Alzheimer disease and frontotemporal dementia
    Friedrichsen, K.
    Mishra, S.
    Ghoshal, N.
    Gordon, B.
    Joseph-Mathurin, N.
    Su, Y.
    Christensen, J.
    Aldea, P.
    McConathy, J.
    Ances, B.
    Cairns, N.
    Morris, J.
    Benzinger, T.
    [J]. JOURNAL OF NEUROCHEMISTRY, 2016, 138 : 383 - 384
  • [27] An updated radiosynthesis of [18F]AV1451 for tau PET imaging
    Mossine A.V.
    Brooks A.F.
    Henderson B.D.
    Hockley B.G.
    Frey K.A.
    Scott P.J.H.
    [J]. EJNMMI Radiopharmacy and Chemistry, 2 (1)
  • [28] Association of In Vivo [18F]AV-1451 Tau PET Imaging Results With Cortical Atrophy and Symptoms in Typical and Atypical Alzheimer Disease
    Xia, Chenjie
    Makaretz, Sara J.
    Caso, Christina
    McGinnis, Scott
    Gomperts, Stephen N.
    Sepulcre, Jorge
    Gomez-Isla, Teresa
    Hyman, Bradley T.
    Schultz, Aaron
    Vasdev, Neil
    Johnson, Keith A.
    Dickerson, Bradford C.
    [J]. JAMA NEUROLOGY, 2017, 74 (04) : 427 - 436
  • [29] Regional Distribution, Asymmetry, and Clinical Correlates of Tau Uptake on [18F]AV-1451 PET in Atypical Alzheimer's Disease
    Tetzloff, Katerina A.
    Graff-Radford, Jonathan
    Martin, Peter R.
    Tosakulwong, Nirubol
    Machulda, Mary M.
    Duffy, Joseph R.
    Clark, Heather M.
    Senjem, Matthew L.
    Schwarz, Christopher G.
    Spychalla, Anthony J.
    Drubach, Daniel A.
    Jack, Clifford R., Jr.
    Lowe, Val J.
    Josephs, Keith A.
    Whitwell, Jennifer L.
    [J]. JOURNAL OF ALZHEIMERS DISEASE, 2018, 62 (04) : 1713 - 1724
  • [30] 18F-AV-1451 in Parkinson’s Disease with and without dementia and in Dementia with Lewy Bodies
    Ruben Smith
    Michael Schöll
    Elisabet Londos
    Tomas Ohlsson
    Oskar Hansson
    [J]. Scientific Reports, 8
12345